Evidence map›Paper›PMID 27234419›Full record

ArticleThe Journal of infectious diseases2016

The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.

Rafael Prados-Rosales, Leandro J Carreño, Brian Weinrick, Ana Batista-Gonzalez, Aarona Glatman-Freedman, Jiayong Xu, John Chan, William R Jacobs, Steven A Porcelli, Arturo Casadevall

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Optimisation ofPharmaceutics · 2020
    Article
  14. Towards new TB vaccines.Seminars in immunopathology · 2020
    Review
  15. Article
  16. TheThe Biochemical journal · 2019
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Rafael Prados-RosalesDepartment of Microbiology and Immunology CIC bioGUNE, Bizkaia Technology Park, Derio, Spain.
Leandro J CarreñoDepartment of Microbiology and Immunology Millennium Institute on Immunology and Immunotherapy, Programa Disciplinario de Inmunologia, Facultad de Medicina, Universidad de Chile, Santiago.
Brian WeinrickDepartment of Microbiology and Immunology Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York.
Ana Batista-GonzalezDepartment of Microbiology and Immunology.
Aarona Glatman-FreedmanDepartment of Pediatrics, and Department of Family and Community Medicine, New York Medical College, Valhalla, New York.
Jiayong XuDepartment of Microbiology and Immunology Department of Medicine.
John ChanDepartment of Microbiology and Immunology Department of Medicine.
William R JacobsDepartment of Microbiology and Immunology Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York.
Steven A PorcelliDepartment of Microbiology and Immunology.
Arturo CasadevallDepartment of Microbiology and Immunology Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Albert Einstein College of Medicine · USCIC bioGUNE · ESHoward Hughes Medical Institute · USJohns Hopkins University · USMillennium Institute on Immunology and Immunotherapy · CLNew York Medical College · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
"The Tuberculous Granuloma"P01AI063537 · NIAID · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI CHAN, JOHN R. · 2005 to 2015
$15.7M
Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
Biology of Fungal MelaninR01AI052733 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 2003 to 2019
$6.6M
Vaccines for Extensively Drug Resistant TuberculosisR01AI098925 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JACOBS, WILLIAM ROBERT · 2012 to 2016
$5.8M
PROTECTIVE ANTIBODIES FOR CRYPTOCOCCAL INFECTIONSR01AI033774 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1994 to 2014
$5.6M
Molecular Characterization of C. neoformans AntibodiesR37AI033142 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CASADEVALL, ARTURO · 2007 to 2016
$3.9M
B cells and humoral immunity in tuberculosisR01AI094745 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CHAN, JOHN R. · 2012 to 2016
$3.2M
Construction of safe and effective live tuberculosis vaccinesR01AI093649 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI PORCELLI, STEVEN A · 2011 to 2015
$2.1M
Molecular dissection of vesiculogenesis in Mycobacterium tuberculosisR21AI115091 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI PRADOS-ROSALES, RAFAEL · 2015 to 2016
$459k
NCI NIH HHS P30 CA013330NHLBI NIH HHS R01 HL059842NIAID NIH HHS P01 AI063537NIAID NIH HHS R01 AI033774NIAID NIH HHS R01 AI052733NIAID NIH HHS R01 AI093649NIAID NIH HHS R01 AI094745NIAID NIH HHS R01 AI098925NIAID NIH HHS R21 AI115091NIAID NIH HHS R37 AI033142
6 · The paper itself

Abstract

backgroundBacillus Calmette-Guerin (BCG) vaccine is widely used for the prevention of tuberculosis, despite limited efficacy. Most immunological studies of BCG or Mycobacterium tuberculosis strains grow bacteria in the presence of detergent, which also strips the mycobacterial capsule. The impact of the capsule on vaccine efficacy has not been explored.

methodsWe tested the influence of detergent in cultures of BCG and M. tuberculosis strains on the outcome of vaccination experiments on mice and transcriptional responses on M. tuberculosis

resultsVaccination of mice with encapsulated BCG promoted a more potent immune response relative to vaccination with unencapsulated BCG, including higher polysaccharide-specific capsule antibody titers, higher interferon γ and interleukin 17 splenic responses, and more multifunctional CD4(+) T cells. These differences correlated with variability in the bacterial burden in lung and spleen of mice infected with encapsulated or unencapsulated M. tuberculosis The combination of vaccination and challenge with encapsulated strains resulted in the greatest protection efficacy. The transcriptome of encapsulated M. tuberculosis was similar to that of starvation, hypoxia, stationary phase, or nonreplicating persistence.

conclusionsThe presence of detergent in growth media and a capsule on BCG were associated with differences in the outcome of vaccination, implying that these are important variables in immunological studies.

Indexed as

Adjuvants, ImmunologicAnimalsAntibodies, BacterialBacterial CapsulesBCG VaccineCD4-Positive T-LymphocytesCulture MediaFemaleGene Expression ProfilingInterferon-gammaInterleukin-17Mice, Inbred C57BLMycobacterium bovisMycobacterium tuberculosisAdjuvants, ImmunologicAntibodies, BacterialBCG VaccineCulture MediaInterferon-gammaInterleukin-17BCGcapsuleMycobacterium tuberculosisvaccine

Identifiers

PMID27234419
PMCPMC4936643
OpenAlexW2396463196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.